Abstract 663: Irreversible covalent azetidine-based small molecule inhibitors of Stat3 activity block growth of human pancreatic tumors
Yue Chen(Cedars-Sinai Medical Center), James Turkson(Cedars-Sinai Medical Center), Ning Zhai(Cedars-Sinai Medical Center), Kayo Nakamura(University of Hawaiʻi at Mānoa), Marcus A. Tius(University of Hawaiʻi at Mānoa), Peibin Yue(University of Central Florida), Wen‐Zhen Fu(Zhengzhou University), Francisco Lopez‐Tapia(Cedars-Sinai Medical Center), Weiliang Chen(University of Hawaiʻi at Mānoa), Christine Brotherton‐Pleiss(University of Hawaiʻi at Mānoa)
Cited by 0
Related Papers
Substrate and Functional Diversity of Lysine Acetylation Revealed by a Proteomics Survey
|Molecular Cell|2006|1.5k
Acetylation Is Indispensable for p53 Activation
|Cell|2008|828
STAT3 as a target for inducing apoptosis in solid and hematological tumors
|Cell Research|2008|489
Phosphotyrosyl Peptides Block Stat3-mediated DNA Binding Activity, Gene Regulation, and Cell Transformation
|Journal of Biological Chemistry|2001|437
Orally bioavailable small-molecule inhibitor of transcription factor Stat3 regresses human breast and lung cancer xenografts
|Proceedings of the National Academy of Sciences|2012|347